New treatment option shows promise in Cushing’s syndrome, according to phase 3 clinical trial data presented by Maria Fleseriu, M.D., during American Association of Clinical Endocrinologists national conference.

A study led by Lara Davis, M.D., finds that patients with metastatic osteosarcoma, a form of bone cancer typically found in children and young adults, had statistically significant improvement in progression-free survival when treated with a multikinase inhibitor called regorafenib.

Employees of Fibre Federal Credit Union raised more than $52,000 to benefit OHSU Doernbecher Children’s Hospital.

Comment from Barry Russman, M.D., about the clinical impacts of Nurinersen for SMA treatment: “It has profoundly changed the way we treat SMA, the most common genetic cause of mortality in infants, but uncertainty remains regarding its efficacy in older patients with Type 3.”

Erick Turner, M.D., is quoted in a story about expensive U.S. drug trials pushing pharmaceutical research overseas.

The Portland Business Journal details National Institutes of Health grant funding in Oregon, noting OHSU earned the vast majority with a total of $245.62 million in 2018 topped by Peter Barr-Gillespie, Ph.D. with five grants totaling $15 million.

OHSU medical student Alex Sievert is quoted as saying “There are some definite centers for excellence for transgender health care, with OHSU being one of them—it’s not like that exists at every medical school,” in a feature story about the OHSU Transgender Health Program.

Patients newly diagnosed with Alzheimer’s disease should consider enrolling in clinical trials for their own treatment and to expand scientific understanding. “It’s vitally needed,” said Jeffrey Kaye, M.D.

OHSU named as being involved in Oregon Enterprise Blockchain Venture Studio, which will help Portland-area startup companies using blockchain technologies.

Testimony from Dana Braner, M.D., and Alanna Braun, M.D., is included in an OPB News story about Oregon House Bill 3063, which would remove non-medical vaccine exemptions.